ICN and Pfizer have jointly developed a Health Risk Assessment (HRA) Instrument to assess nurse’s lifestyle behaviour, with a particular focus on healthy ageing. Thanks to further funding from Pfizer, this instrument will now be expanded to include further questions on immunisation, cholesterol levels and work environment issues.
The new HRA will be sent to selected nurse populations in order to study results and create collateral material to support identified needs. The results will be presented at a “Healthy Nurse” booth at the ICN Conference in Korea in June, where additional data will be collected from participants. Maintaining a healthy workforce is important for both nurses themselves and to protect vulnerable patients.